Suppression of tumour necrosis factor production from mononuclear cells by a novel synthetic compound, CLX-090717.
OBJECTIVES: To evaluate the clinical efficacy of a novel synthetic peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist, CLX-090717, in several in vitro cell culture systems and murine CIA, an experimental model of RA. METHODS: Peripheral blood monocytes purified by elutriation, an...
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|